))
Is Necitumumab An Effective Antibody Against EGFR for Patients with Squamous Lung Cancer?
Manage episode 153141025 series 1082357
Content provided by cancerGRACE - H. Jack West, MD, CancerGRACE - H. Jack West, and MD. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by cancerGRACE - H. Jack West, MD, CancerGRACE - H. Jack West, and MD or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Dr. Nasser Hanna discusses the SQUIRE trial of the EGFR antibody Necitumumab in patients with squamous lung cancer. Though it achieved a statistical increase in OS, he does not consider it clinically relevant.
307 episodes
Share
